Inventor · disambiguated record
Erik Depla
Also filed as: DEPLA ERIK
45 granted patents·39 pending applications·227 citations·filing 1999–2025
98Inventor score
Files withORIONIS BIOSCIENCES INC19INNOGENETICS NV18ABLYNX NV15BOEHRINGER INGELHEIM INT10DEPLA ERIK7
Top patents by PatentIndex Score
84 records- 0192US10550174B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesABLYNX NV·Filed 2017·Granted Feb 4, 2020·6 cites·20 claims
- 0291US9834595B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesABLYNX NV·Filed 2015·Granted Dec 5, 2017·6 cites·10 claims
- 0390US11440943B2Therapeutic interferon alpha 1 proteinsORIONIS BIOSCIENCES INC·Filed 2020·Granted Sep 13, 2022·2 cites·11 claims
- 0490US11161916B2Bispecific binding molecules binding to VEGF and Ang2BOEHRINGER INGELHEIM INT·Filed 2019·Granted Nov 2, 2021·4 cites·5 claims
- 0590US9193780B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesHULTBERG ANNA·Filed 2009·Granted Nov 24, 2015·21 cites·19 claims
- 0688US11384151B2CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsABLYNX NV·Filed 2019·Granted Jul 12, 2022·2 cites·11 claims
- 0788US7238356B2Core-glycosylated HCV envelope proteinsINNOGENETICS NV·Filed 2002·Granted Jul 3, 2007·24 cites·36 claims
- 0887US9527925B2Bispecific binding molecules binding to VEGF and ANG2GSCHWIND ANDREAS·Filed 2012·Granted Dec 27, 2016·16 cites·24 claims
- 0987US7101561B2Purified hepatitis C virus envelope proteins for diagnostic and therapeutic useINNOGENETICS NV·Filed 2001·Granted Sep 5, 2006·21 cites·17 claims
- 1086US9035029B2CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsSINGH SANJAYA·Filed 2013·Granted May 19, 2015·7 cites·36 claims
- 1186US8945567B2Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infectionsDEPLA ERIK·Filed 2010·Granted Feb 3, 2015·8 cites·8 claims
- 1285US10385134B2CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Aug 20, 2019·3 cites·18 claims
- 1384US10414828B2Bispecific binding molecules binding to VEGF and Ang2BOEHRINGER INGELHEIM INT·Filed 2016·Granted Sep 17, 2019·4 cites·13 claims
- 1483US9320792B2Pulmonary administration of immunoglobulin single variable domains and constructs thereofABLYNX NV·Filed 2013·Granted Apr 26, 2016·4 cites·6 claims
- 1582US12221487B2Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domainsABLYNX NV·Filed 2022·Granted Feb 11, 2025·0 cites·20 claims
- 1682US9803001B2Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infectionsABLYNX NV·Filed 2014·Granted Oct 31, 2017·4 cites·6 claims
- 1782US2023203146A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1881US9783612B2CX3CR1-binding polypeptidesBOEHRINGER INGELHEIM INT·Filed 2016·Granted Oct 10, 2017·2 cites·12 claims
- 1981US9725522B2Pulmonary administration of immunoglobulin single variable domains and constructs thereofABLYNX NV·Filed 2016·Granted Aug 8, 2017·2 cites·7 claims
- 2081US7048930B2Expression of core-glycosylated HCV envelope proteins in yeastINNOGENETICS NV·Filed 2002·Granted May 23, 2006·18 cites·34 claims
- 2181US2025066486A1Clec9a binding agents and use thereofORIONIS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2280US12091463B2Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)ORIONIS BIOSCIENCES INC·Filed 2018·Granted Sep 17, 2024·1 cites·8 claims
- 2380US9458235B2Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptidesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Oct 4, 2016·2 cites·2 claims
- 2480US2024360224A1Clec9a binding agents and use thereofORIONIS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2579US11498966B2PD-1 and PD-L1 binding agentsORIONIS BIOSCIENCES INC·Filed 2018·Granted Nov 15, 2022·1 cites·8 claims
- 2679US7413741B2HCV E1 comprising specific disulfide bridgesINNOGENETICS NV·Filed 2005·Granted Aug 19, 2008·8 cites·9 claims
- 2778US11566072B2CD8 binding agentsORIONIS BIOSCIENCES INC·Filed 2018·Granted Jan 31, 2023·1 cites·22 claims
- 2878US9644022B2Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infectionsDEPLA ERIK·Filed 2010·Granted May 9, 2017·4 cites·39 claims
- 2978US2025361305A1Pd-1 and pd-l1 binding agentsORIONIS BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3077US9713589B2Methods and compositions for the preparation of aerosolsDEPLA ERIK·Filed 2011·Granted Jul 25, 2017·4 cites·4 claims
- 3176US12351633B2PD-1 and PD-L1 binding agentsORIONIS BIOSCIENCES INC·Filed 2022·Granted Jul 8, 2025·0 cites·16 claims
- 3276US11007146B2Methods and compositions for the preparation of aerosolsABLYNX NV·Filed 2017·Granted May 18, 2021·1 cites·4 claims
- 3376US6855318B1Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposesINNOGENETICS NV·Filed 2000·Granted Feb 15, 2005·3 cites·29 claims
- 3476US6521403B1Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissueINNOGENETICS NV·Filed 2000·Granted Feb 18, 2003·7 cites·8 claims
- 3575US7314925B2Constructs and methods for expression of recombinant HCV envelope proteinsINNOGENETICS NV·Filed 2002·Granted Jan 1, 2008·8 cites·32 claims
- 3674US6670114B1Host derived proteins binding HCV: medical, diagnostic and purification useINNOGENETICS NV·Filed 2000·Granted Dec 30, 2003·4 cites·13 claims
- 3774US6635257B1Particles of HCV envelope proteins: use for vaccinationINNOGENETICS NV·Filed 1999·Granted Oct 21, 2003·28 cites·28 claims
- 3872US12448447B2CD8 binding agentsORIONIS BIOSCIENCES INC·Filed 2022·Granted Oct 21, 2025·0 cites·14 claims
- 3972US2022017642A1Bispecific binding molecules binding to VEGF and Ang2BOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 4071US12083219B2Methods and compositions for the preparation of aerosolsABLYNX NV·Filed 2021·Granted Sep 10, 2024·0 cites·10 claims
- 4169US2020207845A1Ang2-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 4268US11518799B2Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseasesABLYNX NV·Filed 2019·Granted Dec 6, 2022·0 cites·10 claims
- 4368US2025353890A1Clec9a-based chimeric protein complexesORIONIS BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 4465US12351614B2CLEC9A-based chimeric protein complexesORIONIS BIOSCIENCES INC·Filed 2020·Granted Jul 8, 2025·0 cites·5 claims
- 4564US11028151B2Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infectionsABLYNX NV·Filed 2017·Granted Jun 8, 2021·0 cites·11 claims
- 4664US6841353B2Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissueINNOGENETICS NV·Filed 2002·Granted Jan 11, 2005·1 cites·5 claims
- 4764US2006078932A1Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposesINNOGENETICS NV·Filed 2005·Application pending·0 cites
- 4863US2004126754A1Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposesINNOGENETICS NV·Filed 2003·Application pending·0 cites
- 4962US2024400633A1Split human ifn-gamma and tnf-alpha constructs and uses thereofORIONIS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 5061US2024358826A1Interleukin-1 alpha chimeric proteinORIONIS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 84 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Erik Depla files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →